A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma
Clinical trial NCT01962532 · COMPLETED
Trial details
- NCT number
- NCT01962532
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-21
- Primary completion
- 2016-01-28
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.